-+ 0.00%
-+ 0.00%
-+ 0.00%
10 Health Care Stocks Moving In Monday's Pre-Market Session
Share
Listen to the news

Gainers

  • Icecure Medical (NASDAQ:ICCM) shares moved upwards by 17.7% to $0.68 during Monday's pre-market session. The market value of their outstanding shares is at $39.8 million.
  • Precigen (NASDAQ:PGEN) shares rose 8.17% to $4.1. The company's market cap stands at $1.3 billion.
  • RadNet (NASDAQ:RDNT) stock increased by 7.44% to $75.01. The market value of their outstanding shares is at $5.4 billion. As per the press release, Q4 earnings came out today.
  • Skye Bioscience (NASDAQ:SKYE) shares increased by 7.39% to $0.8. The market value of their outstanding shares is at $23.8 million.

Losers

  • Aardvark Therapeutics (NASDAQ:AARD) shares declined by 54.8% to $5.65 during Monday's pre-market session. The market value of their outstanding shares is at $271.9 million.
  • uniQure (NASDAQ:QURE) shares fell 51.7% to $7.55. The market value of their outstanding shares is at $973.6 million. As per the press release, Q4 earnings came out today.
  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) shares decreased by 16.34% to $5.48. The company's market cap stands at $11.9 million.
  • Ensysce Biosciences (NASDAQ:ENSC) shares declined by 16.24% to $0.52. The market value of their outstanding shares is at $2.2 million.
  • Alzamend Neuro (NASDAQ:ALZN) shares fell 15.43% to $1.7. The market value of their outstanding shares is at $7.6 million.
  • Aptevo Therapeutics (NASDAQ:APVO) shares declined by 15.03% to $6.22. The company's market cap stands at $11.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending